Navigation Links
Founder of Snoring Isn't Sexy, LLC Urges All Dentists to Screen Their Patients for Snoring and Obstructive Sleep Apnea
Date:6/2/2009

Because obstructive sleep apnea is reaching almost epidemic proportions in the United States, Snoring Isn't Sexy, LLC announces an initiative to have all dentists screen their patients for both snoring and sleep apnea.

New York, NY (Vocus) June 2, 2009 -- Because obstructive sleep apnea is reaching almost epidemic proportions in the United States, Snoring Isn't Sexy, LLC announces an initiative to have all dentists screen their patients for both snoring and sleep apnea.

It has been estimated that in the United States alone 20 million men, women and children suffer from obstructive sleep apnea. Millions more snore. Of these 20 million, only about 10% have been diagnosed despite the fact that the average life span of an untreated sleep apneic is years less than those without sleep apnea. Snoring and sleep apnea have been related to heart disease, heart attacks, high blood pressure, stroke, diabetes, obesity, depression and erectile dysfunction as well as vehicular accidental injury and death. The increased medical costs of those with untreated sleep apnea are estimated to be in the billions a year.

In an editorial published in Sleep and Breathing, Vol. 13, No. 1, February, 2009 entitled The recognition and management of sleep-breathing disorders: a mandate for dentistry, Dr. Barsh made the following point "Oral appliance therapy (for the treatment of snoring and sleep apnea) has been accepted as an alternative or supplement to CPAP in some instances and yet the public and many dentists remain unaware of the vital role of the dentist as part of the healthcare team for the recognition and management of snoring and obstructive sleep apnea." In a recent interview, Dr. Barsh added "Because of the close relationship of dentists with our patients, we are in an ideal position to screen our patients for snoring and sleep apnea and either become involved in the management of the problems or refer our patients to those who are. "

Barsh is a past-president of the American Academy of Dental Sleep Medicine (AADSM) and is speaking at the Annual Meeting of the AADSM in Seattle on June 5, 2009.

About Snoring Isn't Sexy, LLC
Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, LLC, and has been involved with sleep medicine since 1992. He now devotes full time to educating the public about dentistry's role and responsibility in the recognition and management of snoring and sleep apnea.

Dr. Barsh and the dentists associated with Snoring Isn't Sexy, LLC feel strongly that management of sleep-breathing disorders is a shared responsibility of both the medical and dental professions.

Snoring Isn't Sexy, LLC consists of independently owned and operated affiliated offices. Visit http://www.SnoringIsntSexy.com for a directory of all participating dentists.

Contact:
Laurence I Barsh, DMD
888.203.0488
www.SnoringIsntSexy.com

###

Read the full story at http://www.prweb.com/releases/snoring/sleep_apnea/prweb2483604.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
2. Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a Clean SCHIP Six-Month Extension
3. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
4. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
5. Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol
6. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
7. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
8. Former NFL Star Tiki Barber and CURE Founder Susan Axelrod Speak Out About Epilepsy on TODAY Show
9. Lenny Dykstra, Founder & President of The Players Club, to Keynote the 2008 Financial Communications Forum
10. Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
11. Childrens Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 2017 , ... The Boulevard is honored to host Shriners and Masons Children’s ... located in the Main West Entrance of The Boulevard (in front of JCPenney). ... necessary and each child with a parent or guardian will be photographed for free ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... News Advisory/Interview ... Choice has helped score a major victory in Europe for public health and the ... , Based on rigorous scientific research and the overwhelming support of European citizens, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Wounded Woman Be Ye Healed-Passing On A Legacy”: ... A Legacy” is the creation of published author, Desiree M Webb, a registered nurse, ... She has been happily married to her husband, Paul, for over twenty-nine years. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden ... innovative patient - centric payment system, to expand its focus on patient care ... patient financial experience. , “At Ogden Clinic, we are working to become ...
(Date:3/23/2017)... ... ... Trainer”: an electrifying and suspenseful gunslinger novel with a twist. “The Trainer” is ... an enthusiasm for action and adventure stories. , Published by Christian Faith ... at the thirty-three notches that lined the edges of the wooden grip plates of ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 ... Enterprises Limited, anuncia el nombramiento de Stuart ... una plataforma de servicios integrados completa para su ... un cargo clave en el crecimiento y ejecución ... será responsable de impulsar todas las actividades de ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
(Date:3/23/2017)... March 23, 2017 /PRNewswire/ - Medicure Inc. ("Medicure" ... specialty pharmaceutical company, is pleased to announce that ... approval from the U.S. Food and Drug Administration ... ("ANDA") for tetrabenazine tablets in the 12.5 mg ... is a generic equivalent of the branded product ...
Breaking Medicine Technology: